MedPath

Comparative study in pharyngitis and / or acute tonsillitis of Cephalexin (Keflex) versus Amoxicilli

Not Applicable
Completed
Conditions
-J029 Acute pharyngitis, unspecified-J039 Acute tonsillitis, unspecified
Acute pharyngitis, unspecified
Acute tonsillitis, unspecified
J029
J039
Registration Number
PER-002-00
Lead Sponsor
ELI LILLY INTERAMERICA INC.,
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients from 2 years to 12 years of age.
Diagnosis of acute pharyngitis or acute tonsillitis (<7 days duration)
Rapid Stret positive test before starting treatment.
The parent or legal representative must sign an informed consent document approved by a CE (Ethics Committee).
The investigator will try to select those patients with a history of complying with the instructions received.

Exclusion Criteria

Patients whose symptoms are due to evident viral infection of the upper respiratory tract.
Researchers and their immediate family members are not allowed to be subjects or patients in studies sponsored by Lilly. As an immediate family member, the researcher´s spouse, parents, children, grandparents or grandchildren are defined.
People who have previously completed this study or have withdrawn from it will not be eligible to participate in this study.
Reaction of severe hypersensitivity prior to cephalosporins or penicillin.
Administration of systemic antibiotics in the 7 days prior to randomization.
Inability to go to valuation consultation.
Concomitant use of probenecid or concomitant treatment with corticosteroids.
History of significant renal deterioration.
Any condition that, in the opinion of the investigator, could impede the evaluation of the response.
Patients who have received an agent in research (a drug that has not been approved for sale in the countries in which this study is conducted) as participants in a study, in the last 30 days.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.